United States Patent 10,966,936: A Detailed Analysis of Scope and Claims
Overview of the Patent
United States Patent 10,966,936, titled "Systems comprising a composite backing and methods for long term transdermal administration," is a patent that focuses on advancements in transdermal delivery systems. This patent is crucial for understanding innovations in the field of pharmaceutical delivery, particularly through the skin.
Background and Context
Transdermal delivery systems have been a significant area of research and development in the pharmaceutical industry. These systems allow for the controlled release of active substances through the skin, providing a convenient and often more effective alternative to oral or injectable medications. The patent in question addresses specific improvements in the design and functionality of these systems.
Scope of the Patent
The scope of this patent is broad and encompasses several key aspects of transdermal delivery technology:
Composite Backing
The patent describes a transdermal delivery system that includes a composite backing. This composite backing is designed to enhance the stability, durability, and effectiveness of the transdermal patch. The backing is typically made from a combination of materials such as polymers, polyethylenes, polypropylenes, and other synthetic materials[1].
Long-Term Administration
One of the primary goals of this patent is to improve the long-term administration of drugs through transdermal patches. The system is designed to ensure consistent and controlled release of the active substance over an extended period, which is crucial for chronic conditions that require ongoing treatment[1].
Materials and Components
The patent details various materials and components used in the construction of the transdermal patch. These include:
- Polymers: Such as polyethylene, polypropylene, and polyvinyl chloride.
- Adhesives: To ensure the patch adheres properly to the skin.
- Active Substances: The drugs or medications that are delivered through the skin.
- Fabric and Film Layers: To enhance the structural integrity and functionality of the patch[1].
Claims of the Patent
The patent includes a series of claims that define the scope of the invention:
Independent Claims
These claims outline the core components and functionalities of the transdermal delivery system, including the composite backing, the adhesive layer, and the active substance layer[1].
Dependent Claims
These claims build upon the independent claims and provide additional details on the materials, construction, and methods of use. For example, they may specify the types of polymers used, the thickness of the layers, and the method of applying the patch to the skin[1].
Key Features and Innovations
Several key features and innovations are highlighted in this patent:
Enhanced Stability and Durability
The composite backing improves the stability and durability of the transdermal patch, ensuring it remains effective over the intended period of use[1].
Controlled Release Mechanism
The system is designed to provide a controlled release of the active substance, which is critical for maintaining therapeutic levels of the drug in the bloodstream[1].
Improved Adhesion
The use of specific adhesives ensures that the patch adheres well to the skin, reducing the risk of it falling off prematurely[1].
Patent Landscape
The patent landscape for transdermal delivery systems is highly competitive and continuously evolving. Here are some key points to consider:
Prior Art and Related Patents
The patent references various prior art and related patents that have contributed to the development of transdermal delivery systems. Understanding these prior arts is essential for appreciating the novelty and non-obviousness of the current invention[1].
Global Patent System
The global patent system, facilitated by initiatives like the Global Dossier and Common Citation Document (CCD), helps in harmonizing patent practices and providing a single point of access to citation data. This is particularly relevant for patents like US 10,966,936, which may have international counterparts and related applications[4].
Economic and Research Implications
The USPTO's Patent Claims Research Dataset provides valuable insights into patent scope and claims trends. This dataset can be used to analyze the economic and research implications of patents like US 10,966,936, including their impact on the pharmaceutical industry and public health[3].
Industry Impact and Future Directions
The impact of this patent on the pharmaceutical industry is significant:
Advancements in Drug Delivery
The improvements in transdermal delivery systems can lead to better patient compliance and more effective treatment outcomes. This is particularly important for chronic conditions where consistent drug levels are crucial[1].
Research and Development
The innovations described in this patent can drive further research and development in the field of pharmaceutical delivery. Companies and researchers may build upon these advancements to create even more sophisticated and effective transdermal systems.
Market Potential
The market potential for advanced transdermal delivery systems is substantial. With the growing demand for convenient and effective drug delivery methods, patents like US 10,966,936 can play a critical role in shaping the future of the pharmaceutical industry.
Key Takeaways
- Composite Backing: The patent introduces a composite backing to enhance the stability and durability of transdermal patches.
- Long-Term Administration: The system is designed for controlled release of active substances over an extended period.
- Materials and Components: Various materials and components are detailed, including polymers, adhesives, and active substances.
- Claims and Scope: The patent includes independent and dependent claims that define the invention's scope.
- Industry Impact: The patent has significant implications for the pharmaceutical industry, driving advancements in drug delivery and research.
FAQs
What is the main focus of United States Patent 10,966,936?
The main focus of this patent is on systems comprising a composite backing for improved long-term transdermal administration of drugs.
What materials are commonly used in the composite backing?
The composite backing typically includes materials such as polymers, polyethylenes, polypropylenes, and other synthetic materials.
How does the patent improve transdermal delivery systems?
The patent improves transdermal delivery systems by enhancing stability, durability, and the controlled release of active substances.
What is the significance of the controlled release mechanism?
The controlled release mechanism ensures that the active substance is released consistently over an extended period, which is crucial for maintaining therapeutic levels of the drug.
How does this patent impact the pharmaceutical industry?
This patent drives advancements in drug delivery, improves patient compliance, and has significant market potential, shaping the future of the pharmaceutical industry.
Where can one find more detailed information about this patent?
More detailed information can be found through the USPTO's public search facilities, the Global Dossier, and the Patent Claims Research Dataset.
Sources
- US10966936B2 - Systems comprising a composite backing and methods for long term transdermal administration - Google Patents
- HYATT v. HIRSHFELD - Court of Appeals for the Federal Circuit
- Patent Claims Research Dataset - USPTO
- Search for patents - USPTO
- U.S. Patent and Trademark Office (USPTO) - USAGov
